Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

M&M to focus on rural markets to boost sales
Utility vehicle maker Mahindra & Mahindra (M&M) Ltd is planning to drive on rural markets to push its latest pick up Mahindra Bolero Maxi Truck.

Investors give thumbs-down to Power Grid's overseas plans
Power Grid ended at Rs 113, lower by Rs 1 or 1.2%, on the BSE.

News of the day

Taro tells shareholders to keep Sun at bay
Ahead of its upcoming annual general meeting on December 31, 2009, Israeli drug firm Taro Pharmaceutical today asked its shareholders to reject a takeover bid by India"s Sun Pharmaceuticals.
Business Ideas

Orchid gets ANDA's final nod from USFDA for Zaleplon Capsules

Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the final Abbreviated New Drug Application (ANDA) approval for its Zaleplon capsules from the US Food and Drug Administration, in a filing to the Bombay Stock Exchange(BSE). - Suven in talks with global drug makers for licensing deal: CEO - Wockhardt divests animal health division - Orchid Pharma settles patent row, stock up 4% - Orchid Pharma settles patent row with Schering-Plough - Ranbaxy, Aurobindo get USFDA nod for migraine drug - Ranbaxy gets GMP approval from Japan The capsules are in strengths of 5 mg and 10 mg and are used in treating insomnia, the filing added. With this approval, the total ANDA approval count of Orchid has gone up to 37 while the total ANDA filings stand at 58, it added. Earlier, on September 16, the pharma firm had received the US drug regulator"s nod for its Piperacillin and Tazobactam injection used to treat infections caused by certain bacteria and accordingly had been granted 180-days generic drug exclusivity.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009